Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Carvedilol in Acute Atrial Fibrillation
NCT02832089Phase 3Completed
- Sponsor
- Andhra Medical College
- Start
- Dec 2000
- Primary completion
- Mar 2002
- Modality
- Small Molecules
01
Overview
Phase 3, open-label, single-arm trial of carvedilol in Atrial fibrillation (AFib), sponsored by Andhra Medical College. Primary endpoint: reduction in ventricular rate at 24 hours. Started Dec 2000; status: completed.
02
Drugs
carvedilol
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT02832089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02832089.